left-caret

NEWS

Paul Hastings Advised Oakley Capital on Investment in ProductLife Group

June 03, 2024

Paul Hastings (Europe) LLP advised Oakley Capital, a leading pan-European private equity investor, on its investment by Oakley Capital Fund V in ProductLife Group, a European provider of outsourced development, regulatory and compliance services to the global life sciences industry.

Oakley will work alongside management and its co-sponsor, 21 Invest - which is reinvesting in the asset via a continuation vehicle - leveraging its buy-and-build track record, supporting the business’ continued international expansion and accelerating investments into AI technology to drive technology enablement of its services and operations.

This complex cross-border deal leveraged Paul Hastings’ private equity capabilities in London and Paris, and the team included partners Anu Balasubramanian, Jamie Holdoway, Charles Cardon, Marc Zerah, and Camille Paulhac; and associates Migle Urbanaviciene, Peter Pedrazzani, Moussa Mbodji, Alisée Rival, and Juliette Hua.

More details on the transaction can be found here.

About Paul Hastings

With widely recognized elite teams in finance, mergers & acquisitions, private equity, restructuring and special situations, litigation, employment, and real estate, Paul Hastings is a premier law firm providing intellectual capital and superior execution globally to the world’s leading investment banks, asset managers, and corporations.

Practice Areas

Private Equity

Mergers and Acquisitions

Life Sciences and Healthcare

Europe


SIGN UP FOR NEWS INSIGHTS

MEDIA CONTACTS

Corporate, Litigation, Real Estate, Intellectual Property, Life Sciences, and Employment

Becca Hatton

Paris

Katy Foster

Europe

Miranda Ward

Submission Requests

Firmwide Inquiries

Elliott Frieder